Project partners – MIROCALS

Project partners

MIROCALS consortium is formed by 12 organisations in the EU to conduct a phase II Proof of Concept / Proof of Mechanism Clinical Trial aiming to test the interleukin-2 (IL-2) as treatment for amyotrophic lateral sclerosis (ALS).

The science of the project is coordinated by Dr Gilbert Bensimon of the University Hospital of Nimes (France) which is the trial sponsor, and Professor P. Nigel Leigh of the Brighton and Sussex Medical School (UK).

Around them, the MIROCALS consortium brings together a strong partnership of: leading scientists and clinicians from six European laboratories in France, Italy, Sweden and UK; two clinical research organisations for professional biobanking and trial regulatory-compliant monitoring; the MND Association one of the most active patients’ associations in the field of neurodegeneration worldwide and an EU project management company.

MIROCALS is a 4-year collaborative research project started in September 2015 and supported by the European Union’s Horizon 2020 research and innovation Programme.

University Hospital of Nimes
Nîmes, France

Inserm Transfert
Paris, France

ICON plc

Evry, France

Humanitas Research Hospital
Milan, Italy

University of Gothenburg

University of Sussex

University of Sheffield


King’s College London
London, UK

Queen Mary University
London, UK

mnda_english_pms_blue-orange-1312748  wgk_welcome-logo-7980536

Motor Neurone Disease Association

WGK Consultancy Ltd